Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2004

01-03-2004 | Original Article

Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women

Authors: O. Sadan, E. Schejter, S. Ginath, R. Bachar, M. Boaz, J. Menczer, M. Glezerman

Published in: Archives of Gynecology and Obstetrics | Issue 3/2004

Login to get access

Abstract.

Israeli Jewish women are at low risk for cancer of the uterine cervix. In view of absent screening programs in Israel, there are only scarce data available with regard to results of PAP smears. The aim of this study was to assess the incidence of premalignant cervical lesions in the largest sample of PAP smears reported so far from Israel. We retrospectively analyzed the results of 297,849 PAP smears, which had been examined in a single laboratory, during 9 years (1991–1999). The incidence of low- and high-grade squamous intraepithelial was 0.69% and 0.29%, respectively. Our data indicate similar incidence rates for premalignant lesions in Jewish Israeli women as observed in Western countries, but no increase during the study period. In spite of relatively high incidence rates for premalignant lesions of the uterine cervix, the incidence rate for invasive cervical cancer remains conspicuously low. For unknown reason the conversion rate from premalignant cervical lesions to invasive cancer is lower in Israeli Jewish women than in European and North American women. We discuss possible reasons for this phenomenon and suggest that at this time mass screening for cervical cancer in Israel may probably not be justified.
Literature
1.
go back to reference Bar-Am A, Niv J, Yavetz H, Jaffa AJ, Peyser RM (1995) Are Israeli women in a low risk group for developing squamous cell carcinoma of the uterine cervix? Acta Obstet Gynecol Scand 74:472–477PubMed Bar-Am A, Niv J, Yavetz H, Jaffa AJ, Peyser RM (1995) Are Israeli women in a low risk group for developing squamous cell carcinoma of the uterine cervix? Acta Obstet Gynecol Scand 74:472–477PubMed
2.
go back to reference Broder S (1992) From the National Institutes of Health. The Bethesda system for reporting cervical/vaginal cytological diagnosis. Report of 1991 workshop. JAMA 267:1892PubMed Broder S (1992) From the National Institutes of Health. The Bethesda system for reporting cervical/vaginal cytological diagnosis. Report of 1991 workshop. JAMA 267:1892PubMed
3.
go back to reference Committee on Gynecologic Practice (1995) Recommendations on frequency of PAP test screening. ACOG committee opinion no 152 Committee on Gynecologic Practice (1995) Recommendations on frequency of PAP test screening. ACOG committee opinion no 152
4.
go back to reference Glezerman M, Piura B, Insler V (1989) Cervical cancer in Jewish women. Am J Obstet Gynecol 161:1186–1190PubMed Glezerman M, Piura B, Insler V (1989) Cervical cancer in Jewish women. Am J Obstet Gynecol 161:1186–1190PubMed
5.
go back to reference Helfand M, O’Connor GT, Zimmer-Gembeck M (1992) Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘88) on the incidence of invasive cervical cancer. Med Care 30:1067–1082PubMed Helfand M, O’Connor GT, Zimmer-Gembeck M (1992) Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘88) on the incidence of invasive cervical cancer. Med Care 30:1067–1082PubMed
6.
go back to reference Magnusson PKE, Sparen P, Gyllensten UB (1999) Genetic link to cervical tumors. Nature 400:29–30PubMed Magnusson PKE, Sparen P, Gyllensten UB (1999) Genetic link to cervical tumors. Nature 400:29–30PubMed
7.
go back to reference Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA (1999) Identifying women with cervical neoplasia using human papilloma virus NA testing for equivocal Papanicolaou results. JAMA 281:1605–1610PubMed Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA (1999) Identifying women with cervical neoplasia using human papilloma virus NA testing for equivocal Papanicolaou results. JAMA 281:1605–1610PubMed
8.
go back to reference Menczer J, Fintsi Y, Arbel-Alon S, Tell L, Friedman E, Jackman A, Sherman L (2000) The presence of HPV 16:18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Eur J Gynaecol Oncol 21:30–34PubMed Menczer J, Fintsi Y, Arbel-Alon S, Tell L, Friedman E, Jackman A, Sherman L (2000) The presence of HPV 16:18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Eur J Gynaecol Oncol 21:30–34PubMed
9.
go back to reference Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606PubMed Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606PubMed
10.
go back to reference Ponten J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparen P, Trichopoulos D (1995) Strategies for global control of cervical cancer. Int J Cancer 60:1–26PubMed Ponten J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparen P, Trichopoulos D (1995) Strategies for global control of cervical cancer. Int J Cancer 60:1–26PubMed
11.
go back to reference Ries L, Miller B, Haskey B (1994) SEER cancer statistic review 1973–1991, National Cancer Institute publ no 94-2789 Ries L, Miller B, Haskey B (1994) SEER cancer statistic review 1973–1991, National Cancer Institute publ no 94-2789
12.
go back to reference Schachter A, Avraham E (1984) Changing trends of cervical neoplasia in Israeli Jews. Lancet II:1150CrossRef Schachter A, Avraham E (1984) Changing trends of cervical neoplasia in Israeli Jews. Lancet II:1150CrossRef
13.
go back to reference van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM (2000) Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81:317–325PubMed van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM (2000) Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81:317–325PubMed
Metadata
Title
Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women
Authors
O. Sadan
E. Schejter
S. Ginath
R. Bachar
M. Boaz
J. Menczer
M. Glezerman
Publication date
01-03-2004
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 3/2004
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-002-0371-y

Other articles of this Issue 3/2004

Archives of Gynecology and Obstetrics 3/2004 Go to the issue